Lanean...

ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

We hypothesized that circulating tumor DNA (ctDNA) molecular residual disease (MRD) analysis without prior mutational knowledge could be performed after neoadjuvant chemotherapy to assess oligometastatic colorectal cancer (CRC) treated surgically with curative intent. We also investigated urine as a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCO Precis Oncol
Egile Nagusiak: Pellini, Bruna, Pejovic, Nadja, Feng, Wenjia, Earland, Noah, Harris, Peter K., Usmani, Abul, Szymanski, Jeffrey J., Qaium, Faridi, Mudd, Jacqueline, Petty, Marvin, Jiang, Yuqiu, Singh, Ashla, Maher, Christopher A., Henke, Lauren E., Park, Haeseong, Ciorba, Matthew A., Kim, Hyun, Mutch, Matthew G., Pedersen, Katrina S., Tan, Benjamin R., Hawkins, William G., Fields, Ryan C., Chaudhuri, Aadel A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2021
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8232837/
https://ncbi.nlm.nih.gov/pubmed/34250420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00276
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!